Health News Releases

17:20

Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform

Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appoi

15:41

SINOVAC Announces Record and Distribution Dates for Special Cash Dividend

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as pre

09:50

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54244430&newsitemid=20250428931117&lan=en-US&anchor=HistoSonics&index=1&md5=654c6b5b28f131e64dc

April 29, 17:10

SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public le

April 29, 15:30

Actus Nutrition Acquires Protein Facility from Foremost Farms USA

Actus Nutrition (“Actus”), a leading vertically-integrated nutritional ingredients manufacturer and portfolio company of Butterfly Equity (“Butterfly”), today finalized an agreement to purchase a 99,0

April 29, 09:50

Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine

Ferrer (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ferrer.com&esheet=54244013&newsitemid=20250427034068&lan=en-US&anchor=Ferrer&index=1&md5=d54ab3f5c9071597c756ac15dea5202e),

April 27, 11:30

Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows

With the introduction of the VIO® 3n, Erbe Elektromedizin GmbH expands its established VIO® 3 family with a new generation of electrosurgical generators, specifically tailored to different medical spe

April 25, 10:00

PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea

PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is acquiring an entire equity stake in Ajinomoto A

April 24, 16:10

Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis

H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 m

April 24, 14:15

Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. · Net sales: Achieved 1,129 million USD in net sales, u

April 24, 10:30

QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models p

April 23, 15:00

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay

Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State Department of Health

April 23, 14:35

Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai

Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in

April 22, 16:38

A new weapon in the global fight against malaria

Malaria is one of the world’s most deadly diseases, and it is becoming more pervasive - despite decades of effort and some successes on the path to eradicating it. According to the World Health Organi

April 22, 10:35

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug d

April 22, 10:20

Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1

Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in patients with high-risk Bacillus Calmette-Gu

April 20, 11:45

Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Re

April 18, 09:55

Avania Strengthens Leadership Team With Pivotal Executive Appointments

Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54239395&newsitemid=20250417247152&lan=en-US&anchor=Avania&index=1&md5=8135dbc072fb2e6f4bf0a0

April 18, 09:45

Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3 trillion market

Abu Dhabi has launched the groundbreaking life sciences cluster, reinforcing its position as a global hub for biotechnology, MedTech, and digital health. Developed by the Abu Dhabi Department of Econo

April 17, 16:39

Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®

Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their late

April 17, 11:20

Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundat

April 15, 14:35

Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets

Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.[1]-[7],[11]-[14] This follows Sculptra’

April 13, 10:25

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an inve

April 13, 10:15

Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a sig

April 10, 15:00

Natus Sensory Strengthens Executive Team with Key Leadership Appointments

Natus Sensory (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnatus.com%2F&esheet=54235965&newsitemid=20250409771212&lan=en-US&anchor=Natus+Sensory&index=1&md5=c24865accf8cec644da2a

News by Region

News by Industry